China’s CanSinoBIO vaccine 57.5% effective against COVID-19, trial study shows
BEIJING: The peer-reviewed results from a large trial showed that CanSino Biologics Inc's vaccine was 57.5% effective against symptomatic COVID-19 ...
BEIJING: The peer-reviewed results from a large trial showed that CanSino Biologics Inc's vaccine was 57.5% effective against symptomatic COVID-19 ...
In the heart of Karachi, amidst the bustling city, a young woman named Ayesha, a polio vaccinator, embarked on her...
Read more© 2023DAILY PATRIOT - For the latest news updates from the Daily Patriot. Download Our Apps
© 2023DAILY PATRIOT - For the latest news updates from the Daily Patriot. Download Our Apps